AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29049845 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention group (IG)
Number of subjects: 53
Study 26949110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian stimulation with clomiphene citrate, letrozole, or gonadotropins for up to four cycles or until pregnancy was achieved
Number of subjects: 900
Study 25564086 — intervention group
Group type: EXPERIMENTAL
Intervention: Susceptibles
Number of subjects: 37
Study 25564086 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 37
Study 22735461 — intervention group
Group type: EXPERIMENTAL
Intervention: R1663 after a high fat/high calorie breakfast
Number of subjects: 8
Study 22735461 — intervention group
Group type: COMPARATOR
Intervention: R1663 after an overnight fast of 10 h
Number of subjects: 8
Study 20446252 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal lidocaine gel (10 cc of 2% lidocaine)
Number of subjects: 100
Study 20446252 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprostatic nerve block (10 cc of 1% lidocaine solution)
Number of subjects: 100
Study 20446252 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 cc of ultrasound gel)
Number of subjects: 100
Study 18782804 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 degrees laser retinopexy
Number of subjects: 303
Study 18782804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laser treatment)
Number of subjects: 303
Study 15830637 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1RN gene polymorphism
Number of subjects: 96
Study 15830637 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1B-511 gene polymorphism
Number of subjects: 96
Study 14655739 — intervention group
Group type: EXPERIMENTAL
Intervention: FCDS‐DC (GamCath Dolphin GDK 11 French, length 12.5 or 15 cm)
Number of subjects: 20
Study 14655739 — intervention group
Group type: COMPARATOR
Intervention: STD‐DC (GamCath GDK 11 French, length 12.5 or 15 cm)
Number of subjects: 20
Study 10786218 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6 polymorphic alleles identified using allele specific nested PCR reaction
Number of subjects: 22
Study 10786218 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 22
Study 8912802 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% nitrous oxide
Number of subjects: 11
Study 8912802 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% nitrous oxide
Number of subjects: 11
Study 8912802 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% nitrous oxide
Number of subjects: 11
Study 8912802 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% nitrous oxide
Number of subjects: 11
Study 8912802 — intervention group
Group type: COMPARATOR
Intervention: Placebo oxygen
Number of subjects: 11
Study 1833126 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose oral contraceptives (20 micrograms ethinyl estradiol and 150 micrograms desogestrel per day)
Number of subjects: 20
Study 1833126 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose oral contraceptives (50 micrograms ethinyl estradiol and 125 micrograms desogestrel per day)
Number of subjects: 20
Study 1833126 — intervention group
Group type: COMPARATOR
Intervention: Control (before drug ingestion)
Number of subjects: 20
Study 6285744 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (1.25 mg daily, orally)
Number of subjects: 18
Study 6285744 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous estradiol (5 gm ointment, 3 mg E2, applied each evening)
Number of subjects: 18
Study 31140202 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 333
Study 31140202 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin intervention
Number of subjects: 333
Study 31140202 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 333
Study 28901333 — intervention group
Group type: EXPERIMENTAL
Intervention: Paleolithic-type diet (PD)
Number of subjects: 70
Study 28901333 — intervention group
Group type: COMPARATOR
Intervention: Nordic Nutrition Recommendations (NNR) diet
Number of subjects: 70
Study 26245498 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone agonist (GnRHa) goserelin, which causes a net decrease in sex-steroid levels.
Number of subjects: 58
Study 26245498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 26245498 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone agonist (GnRHa) goserelin
Number of subjects: 58
Study 25267532 — intervention group
Group type: EXPERIMENTAL
Intervention: Carers' assessment, skills and information sharing (C) intervention + treatment as usual (TAU)
Number of subjects: 178
Study 25267532 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 178
Study 22253096 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical overvaluation of shape and weight (determined by EDE)
Number of subjects: 116
Study 20659948 — intervention group
Group type: EXPERIMENTAL
Intervention: Dior PCB
Number of subjects: 57
Study 20659948 — intervention group
Group type: COMPARATOR
Intervention: Taxus DES
Number of subjects: 57
Study 17287932 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Escherichia coli Nissle 1917 (EcN) solution, 1-3 ml per day (10^8 viable EcN cells per millilitre)
Number of subjects: 113
Study 17287932 — intervention group
Group type: COMPARATOR
Intervention: Placebo suspension
Number of subjects: 113
Study 17287932 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Escherichia coli Nissle 1917 (EcN) solution
Number of subjects: 113
Study 16146477 — intervention group
Group type: EXPERIMENTAL
Intervention: 26G Atraucan spinal needle
Number of subjects: 303
Study 16146477 — intervention group
Group type: EXPERIMENTAL
Intervention: 27G Whitacre spinal needle
Number of subjects: 303
Study 16146477 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 303
Study 12811371 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin treatment
Number of subjects: 30
Study 10556126 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg by mouth, every 8 hours for 3 days)
Number of subjects: 9
Study 10556126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8693526 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 10
Study 2015395 — intervention group
Group type: EXPERIMENTAL
Intervention: IDR/Ara‐C
Number of subjects: 130
Study 2015395 — intervention group
Group type: COMPARATOR
Intervention: DNR/Ara‐C
Number of subjects: 130
Study 6177441 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin therapy added to hypovolaemia treatment
Number of subjects: 70
Study 30865917 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral targeted therapy or chemotherapy
Number of subjects: 181
Study 28461543 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening (self-initiated, patient-directed via headphones)
Number of subjects: 307
Study 28461543 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety levels (measured daily with a visual analog scale)
Number of subjects: 307
Study 28461543 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedative exposure (daily sedation intensity score and sedative dose frequency)
Number of subjects: 307
Study 28461543 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical factors (illness severity, days of weaning trials, tracheostomy placement)
Number of subjects: 307
Study 26355168 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone substitute covered with a resorbable membrane (BG group)
Number of subjects: 97
Study 26355168 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement (OFD group)
Number of subjects: 97
Study 23806013 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral techniques combined with virtual reality, biofeedback, and mobile phone.
Number of subjects: 150
Study 23806013 — intervention group
Group type: COMPARATOR
Intervention: Traditional stress management CBT-based training without the use of new technologies.
Number of subjects: 150
Study 23806013 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiting list group reassessed after five weeks, then randomly assigned to one of the two treatments.
Number of subjects: 150
Study 21993933 — intervention group
Group type: EXPERIMENTAL
Intervention: LESS cholecystectomy
Number of subjects: 40
Study 21993933 — intervention group
Group type: COMPARATOR
Intervention: Standard four-port laparoscopic cholecystectomy
Number of subjects: 40
Study 19241361 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupled plasma filtration adsorption (CPFA)
Number of subjects: 7
Study 19241361 — intervention group
Group type: COMPARATOR
Intervention: High-volume hemofiltration (HVHF)
Number of subjects: 7
Study 18039105 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent advances in understanding the genetics of IBD and the immunology of host‐microbial interaction.
Number of subjects: 0
Study 10764365 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse management
Number of subjects: 1815
Study 10764365 — intervention group
Group type: COMPARATOR
Intervention: General practitioner management
Number of subjects: 1815
Study 10764365 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse consultations
Number of subjects: 1815
Study 10764365 — intervention group
Group type: COMPARATOR
Intervention: Doctor consultations
Number of subjects: 1815
Study 10764365 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse prescriptions
Number of subjects: 1815
Study 10764365 — intervention group
Group type: COMPARATOR
Intervention: Doctor prescriptions
Number of subjects: 1815
Study 10764365 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse management without doctor input
Number of subjects: 1815
Study 8968035 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 1600 mg daily by mouth
Number of subjects: 133
Study 8968035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 1293650 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg) - two doses (the previous night and before surgery)
Number of subjects: 105
Study 1293650 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg) - two doses (the previous night and before surgery)
Number of subjects: 105
Study 1293650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 1293650 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg) - the night prior to surgery
Number of subjects: 105
Study 1293650 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg) - the night before
Number of subjects: 105
Study 1293650 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg) - two doses (the previous night and before surgery)
Number of subjects: 105
Study 6085358 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (1.0 mg intravenous)
Number of subjects: 6
Study 6085358 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (1.0 mg intravenous)
Number of subjects: 6
Study 31441401 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebijing injection
Number of subjects: 0
Study 31441401 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 30292081 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + PR
Number of subjects: 40
Study 30292081 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 40
Study 26773917 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy plus physical exercise (n=7)
Number of subjects: 14
Study 26773917 — intervention group
Group type: COMPARATOR
Intervention: Only pharmacotherapy (n=7)
Number of subjects: 14
Study 24559809 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy (H)
Number of subjects: 164
Study 24559809 — intervention group
Group type: COMPARATOR
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 164
Study 24559809 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT with Hypnotherapy (HNRT)
Number of subjects: 164
Study 24559809 — intervention group
Group type: COMPARATOR
Intervention: Self-quit group
Number of subjects: 164
Study 22588010 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intensified cognitive behavioral therapy (CBT) and/or pharmacotherapy
Number of subjects: 500
Study 22588010 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 500
Study 20430686 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT)
Number of subjects: 30
Study 20430686 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Palpation (MP)
Number of subjects: 30
Study 20430686 — intervention group
Group type: EXPERIMENTAL
Intervention: Algometry
Number of subjects: 30
Study 18018782 — intervention group
Group type: EXPERIMENTAL
Intervention: Diprivan/Ketamine (D/K)
Number of subjects: 60
Study 18018782 — intervention group
Group type: COMPARATOR
Intervention: Midazolam/Ketamine (M/K)
Number of subjects: 60
Study 15692141 — intervention group
Group type: COMPARATOR
Intervention: APAP alone
Number of subjects: 10
Study 15692141 — intervention group
Group type: EXPERIMENTAL
Intervention: APAP + DPH
Number of subjects: 10
Study 15692141 — intervention group
Group type: EXPERIMENTAL
Intervention: APAP + OXY
Number of subjects: 10
Study 12239942 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐isosorbide mononitrate (80 mg/day)
Number of subjects: 30
Study 12239942 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (added after 4 weeks)
Number of subjects: 30
Study 12239942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10428402 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonologic speech intervention (SI)
Number of subjects: 29
Study 10428402 — intervention group
Group type: COMPARATOR
Intervention: Articulatory speech intervention (SI)
Number of subjects: 29
Study 7671352 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 182
Study 7671352 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 182
Study 2147621 — intervention group
Group type: EXPERIMENTAL
Intervention: 40‐80 mg ketanserin daily for 4 months
Number of subjects: 20
Study 2147621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30487058 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy for primary prevention of atherosclerotic events
Number of subjects: 1825
Study 30487058 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and long history of diabetes
Number of subjects: 1825
Study 28862406 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiosal (NaCl + Chitosan 3%)
Number of subjects: 41
Study 28862406 — intervention group
Group type: COMPARATOR
Intervention: NaCl (standard table marine salt)
Number of subjects: 41
Study 26072302 — intervention group
Group type: EXPERIMENTAL
Intervention: Periarticular anesthesia (ropivacaine 1% 20 mL)
Number of subjects: 0
Study 26072302 — intervention group
Group type: COMPARATOR
Intervention: Oral and intravenous analgesia alone
Number of subjects: 0
Study 24246210 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidafenacin 0.1 mg twice daily for 12 weeks
Number of subjects: 0
Study 24246210 — intervention group
Group type: COMPARATOR
Intervention: Fesoterodine 4 mg once daily for 12 weeks
Number of subjects: 0
Study 24246210 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidafenacin
Number of subjects: 0
Study 24246210 — intervention group
Group type: COMPARATOR
Intervention: Fesoterodine
Number of subjects: 0
Study 22047071 — intervention group
Group type: EXPERIMENTAL
Intervention: Television Assisted Prompting (TAP)
Number of subjects: 23
Study 22047071 — intervention group
Group type: COMPARATOR
Intervention: Typical (TYP) practice (without TAP reminders)
Number of subjects: 23
Study 22047071 — intervention group
Group type: COMPARATOR
Intervention: Self-selected preferred tasks
Number of subjects: 23
Study 22047071 — intervention group
Group type: COMPARATOR
Intervention: Self-selected non-preferred tasks
Number of subjects: 23
Study 20033133 — intervention group
Group type: EXPERIMENTAL
Intervention: QSU-brief
Number of subjects: 60
Study 20033133 — intervention group
Group type: EXPERIMENTAL
Intervention: MPSS
Number of subjects: 60
Study 20033133 — intervention group
Group type: EXPERIMENTAL
Intervention: CR
Number of subjects: 60
Study 20033133 — intervention group
Group type: EXPERIMENTAL
Intervention: MNWS
Number of subjects: 60
Study 20033133 — intervention group
Group type: EXPERIMENTAL
Intervention: SS
Number of subjects: 60
Study 20033133 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued smoking)
Number of subjects: 60
Study 17692977 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative 5x5Gy irradiation followed by surgery within 7 days
Number of subjects: 316
Study 17692977 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiation (50.4 Gy, 1.8Gy per fraction plus boluses of 5‐fluorouracil and leucovorin) followed by surgery after 4‐6 weeks
Number of subjects: 316
Study 15884761 — intervention group
Group type: EXPERIMENTAL
Intervention: c9,t11 CLA
Number of subjects: 25
Study 15884761 — intervention group
Group type: EXPERIMENTAL
Intervention: t10,c12 CLA
Number of subjects: 25
Study 15884761 — intervention group
Group type: COMPARATOR
Intervention: Oleic acid
Number of subjects: 25
Study 12473833 — intervention group
Group type: EXPERIMENTAL
Intervention: d4T (stavudine) in combination with lamivudine and indinavir
Number of subjects: 155
Study 12473833 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV (zidovudine) in combination with lamivudine and indinavir
Number of subjects: 155
Study 12473833 — intervention group
Group type: COMPARATOR
Intervention: Control group (susceptible virus)
Number of subjects: 155
Study 12473833 — intervention group
Group type: COMPARATOR
Intervention: Control group (resistant virus)
Number of subjects: 155
Study 9796224 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to melodies (study phase)
Number of subjects: 0
Study 9796224 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition of studied melodies
Number of subjects: 0
Study 9796224 — intervention group
Group type: EXPERIMENTAL
Intervention: Study-to-test changes in melody timbre and manipulation of study tasks
Number of subjects: 0
Study 9796224 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition task
Number of subjects: 0
Study 9796224 — intervention group
Group type: EXPERIMENTAL
Intervention: Affect task
Number of subjects: 0
Study 7785684 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial tears instillation in normal eyes
Number of subjects: 38
Study 7785684 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial tears instillation in postkeratoplasty eyes
Number of subjects: 38
Study 2552342 — intervention group
Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 7
Study 2552342 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7
Study 510206 — intervention group
Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum immune stimulation
Number of subjects: 120
Study 510206 — intervention group
Group type: COMPARATOR
Intervention: VAC chemotherapy (vincristin, adriamycin, cyclophosphamide)
Number of subjects: 120
Study 510206 — intervention group
Group type: COMPARATOR
Intervention: FMC chemotherapy (fluorouracil, methotrexate, cyclophosphamide)
Number of subjects: 120
Study 31418908 — intervention group
Group type: EXPERIMENTAL
Intervention: e-CBT (cognitive behavioural therapy with an email-based recording and reminding system for 20 days)
Number of subjects: 30
Study 31418908 — intervention group
Group type: EXPERIMENTAL
Intervention: s-CBT (cognitive behavioural therapy with a sticky note reminder for 20 days)
Number of subjects: 30
Study 31418908 — intervention group
Group type: COMPARATOR
Intervention: Control group (simple verbal instructions to avoid nFTC for 20 days)
Number of subjects: 30
Study 31257096 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation of the subthalamic nucleus (STN‐DBS)
Number of subjects: 114
Study 29143799 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolysed whey protein formula supplemented with starch and Lactobacillus reuteri (DSM 17938)
Number of subjects: 80
Study 29143799 — intervention group
Group type: COMPARATOR
Intervention: Standard starter formula
Number of subjects: 80
Study 25744688 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback plus transanal electrostimulation
Number of subjects: 0
Study 25744688 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (diet, exercise, laxatives)
Number of subjects: 0
Study 23791697 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum with CPP-ACP (trident total)
Number of subjects: 12
Study 23791697 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum without CPP-ACP (trident)
Number of subjects: 12
Study 23791697 — intervention group
Group type: COMPARATOR
Intervention: Control (no chewing gum)
Number of subjects: 12
Study 21906879 — intervention group
Group type: EXPERIMENTAL
Intervention: PC-PEP (Pain Consultation combined with Pain Education Program)
Number of subjects: 72
Study 21906879 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 72
Study 19382493 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Rhino Mannheim
Number of subjects: 32
Study 19382493 — intervention group
Group type: COMPARATOR
Intervention: Netcell Series 5000
Number of subjects: 32
Study 17028770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography plus sonography
Number of subjects: 162
Study 17028770 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical examination plus mammography and sonography
Number of subjects: 162
Study 17028770 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical examination
Number of subjects: 162
Study 17028770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography and sonography
Number of subjects: 162
Study 15042229 — intervention group
Group type: COMPARATOR
Intervention: Insecticide-treated curtains (ITC) provided to half the population in 1994, with re-treatment or replacement annually.
Number of subjects: 100000
Study 15042229 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ITC provided until 1996).
Number of subjects: 100000
Study 11033398 — intervention group
Group type: EXPERIMENTAL
Intervention: Amvisc Plus (sodium hyaluronate 1.6%)
Number of subjects: 50
Study 11033398 — intervention group
Group type: EXPERIMENTAL
Intervention: OcuCoat (hydroxypropyl methylcellulose 2%)
Number of subjects: 50
Study 11033398 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscoat (chondroitin sulfate 4%-sodium hyaluronate 3%)
Number of subjects: 50